Published in
Taylor and Francis Group, OncoImmunology, 5(6), p. e1308616, 2017
DOI: 10.1080/2162402x.2017.1308616
Links
Tools
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Journal article published in 2017 by
Masaki Terabe,
Faith C. Robertson 
,
Katharine Clark ,
Emma De Ravin,
Anja Bloom,
David J. Venzon,
Shingo Kato,
Amer Mirza,
Jay A. Berzofsky
,
Katharine Clark ,
Emma De Ravin,
Anja Bloom,
David J. Venzon,
Shingo Kato,
Amer Mirza,
Jay A. Berzofsky
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 